Nothing Special   »   [go: up one dir, main page]

GB201405775D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB201405775D0
GB201405775D0 GBGB1405775.6A GB201405775A GB201405775D0 GB 201405775 D0 GB201405775 D0 GB 201405775D0 GB 201405775 A GB201405775 A GB 201405775A GB 201405775 D0 GB201405775 D0 GB 201405775D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1405775.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HOSPITAL OF NORTH NORWAY, University of
TROMS, University of
Original Assignee
HOSPITAL OF NORTH NORWAY, University of
TROMS, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HOSPITAL OF NORTH NORWAY, University of, TROMS, University of filed Critical HOSPITAL OF NORTH NORWAY, University of
Priority to GBGB1405775.6A priority Critical patent/GB201405775D0/en
Publication of GB201405775D0 publication Critical patent/GB201405775D0/en
Priority to DK15713749T priority patent/DK3126391T3/en
Priority to AU2015239606A priority patent/AU2015239606C1/en
Priority to CA2943857A priority patent/CA2943857C/en
Priority to IL247988A priority patent/IL247988B2/en
Priority to RU2016142718A priority patent/RU2688627C2/en
Priority to US15/300,656 priority patent/US10882919B2/en
Priority to MEP-2019-328A priority patent/ME03655B/en
Priority to LTEP15713749.8T priority patent/LT3126391T/en
Priority to MX2016012620A priority patent/MX2016012620A/en
Priority to NZ724772A priority patent/NZ724772A/en
Priority to ES15713749T priority patent/ES2757596T3/en
Priority to BR112016022508A priority patent/BR112016022508A2/en
Priority to SI201531002T priority patent/SI3126391T1/en
Priority to EP15713749.8A priority patent/EP3126391B1/en
Priority to PL15713749T priority patent/PL3126391T3/en
Priority to HUE15713749A priority patent/HUE047455T2/en
Priority to RS20191490A priority patent/RS59704B1/en
Priority to PCT/EP2015/057102 priority patent/WO2015150417A1/en
Priority to PT157137498T priority patent/PT3126391T/en
Priority to CY20191101228T priority patent/CY1122728T1/en
Priority to HRP20192097TT priority patent/HRP20192097T1/en
Priority to US17/116,882 priority patent/US11725063B2/en
Ceased legal-status Critical Current

Links

GBGB1405775.6A 2014-03-31 2014-03-31 Antibodies Ceased GB201405775D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GBGB1405775.6A GB201405775D0 (en) 2014-03-31 2014-03-31 Antibodies
PT157137498T PT3126391T (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
NZ724772A NZ724772A (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
BR112016022508A BR112016022508A2 (en) 2014-03-31 2015-03-31 antibodies to hpa-1a
CA2943857A CA2943857C (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
IL247988A IL247988B2 (en) 2014-03-31 2015-03-31 ANTIBODIES AGAINST HPA-1a
RU2016142718A RU2688627C2 (en) 2014-03-31 2015-03-31 ANTIBODIES TO HPA-1a
US15/300,656 US10882919B2 (en) 2014-03-31 2015-03-31 Antibodies against HPA-1a
MEP-2019-328A ME03655B (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
LTEP15713749.8T LT3126391T (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
MX2016012620A MX2016012620A (en) 2014-03-31 2015-03-31 ANTIBODIES AGAINST HPA-1a.
DK15713749T DK3126391T3 (en) 2014-03-31 2015-03-31 ANTIBODIES AGAINST HPA-1a
ES15713749T ES2757596T3 (en) 2014-03-31 2015-03-31 Antibodies against HPA-1a
AU2015239606A AU2015239606C1 (en) 2014-03-31 2015-03-31 Antibodies against HPA-1a
SI201531002T SI3126391T1 (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
EP15713749.8A EP3126391B1 (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
PL15713749T PL3126391T3 (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
HUE15713749A HUE047455T2 (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
RS20191490A RS59704B1 (en) 2014-03-31 2015-03-31 Antibodies against hpa-1a
PCT/EP2015/057102 WO2015150417A1 (en) 2014-03-31 2015-03-31 ANTIBODIES AGAINST HPA-1a
HRP20192097TT HRP20192097T1 (en) 2014-03-31 2019-11-21 ANTIBODIES AGAINST HPA-1a
CY20191101228T CY1122728T1 (en) 2014-03-31 2019-11-21 ANTIBODIES AGAINST HPA-1A
US17/116,882 US11725063B2 (en) 2014-03-31 2020-12-09 Antibodies against HPA-1a

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1405775.6A GB201405775D0 (en) 2014-03-31 2014-03-31 Antibodies

Publications (1)

Publication Number Publication Date
GB201405775D0 true GB201405775D0 (en) 2014-05-14

Family

ID=50737751

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1405775.6A Ceased GB201405775D0 (en) 2014-03-31 2014-03-31 Antibodies

Country Status (1)

Country Link
GB (1) GB201405775D0 (en)

Similar Documents

Publication Publication Date Title
IL250583A0 (en) Anti-tigit antibodies
IL252004A0 (en) Domain-exchanged antibody
SG11201703403TA (en) Anti-tim-3 antibodies
SG11201703346PA (en) Anti-tim-3 antibodies
IL252422A0 (en) Effector-deficient anti-cd32a antibodies
IL291164A (en) Anti-nme antibody
IL246603A0 (en) Novel anti-netrin-1 antibody
IL250374B (en) Anti-ceramide antibodies
GB201410520D0 (en) Antibody
SG11201700922YA (en) Anti-orai1 antibody
LT3628731T (en) Novel anti-presepsin antibody
IL247988A0 (en) Antibodies against hpa-1a
GB201419092D0 (en) Anti-TIM-3 antibodies
GB201419089D0 (en) Anti-TIM-3 antibodies
GB201417614D0 (en) Antibodies
GB201414270D0 (en) Antibodies
GB201418776D0 (en) Antibody
GB201405775D0 (en) Antibodies
GB201401200D0 (en) Antibodies
GB201413745D0 (en) Antibody
GB201411319D0 (en) Antibody
GB201407535D0 (en) Antibody Drug - Conjugates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)